AQP4 and myeloid sarcoma: Interestingly, in contrast with MS, one case series suggested that Myo levels are decreased in spinal cord lesions of patients with AQP4+NMOSD compared to both MS and healthy controls, possibly reflecting the disease-specific astrocyte damage (134).